FDA 483 - Newark Beth Israel Medical Center - Blood Bank - October 13, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Newark Beth Israel Medical Center - Blood Bank revealed significant deficiencies in adhering to written standard operating procedures and maintaining accurate records. The firm failed to follow procedures for blood irradiator verification and quality control, resulting in incomplete and inaccurate documentation. Additionally, records for processing blood and blood components were not concurrently maintained, lacking crucial details for traceability.
- Inspection Date
- October 13, 2023
- Product Type
- Biologics
- Person
ID · 45bf3f07-1fef-4014-8977-7faa61df00e3